Tag: Vaccines
CDC Supports Second COVID-19 Booster for Americans 50 Years and Older
Echoing the FDA, the CDC also supported a second booster for 'certain immune-compromised individuals'
Booster Strategies After Janssen Shot Increased Protection Against Omicron
Vaccination with one Janssen dose plus mRNA booster provides higher protection than two Janssen doses
COVID-19 Vaccination Not Linked to Peripartum Adverse Outcomes
Large population-based cohort of more than 22,000 women shows no increased risks with vaccination during pregnancy
No Adverse Outcomes Seen With SARS-CoV-2 Vaccination in Pregnancy
No significantly increased risk reported for preterm birth, stillbirth, SGA, low Apgar score, or neonatal care admission
FDA Approves Second COVID-19 Booster for Americans 50+
Agency also authorized a second booster for Americans 12 and older who are immune-compromised
Live Attenuated Flu Vaccine Does Not Increase Frequency of Asthma Exacerbations
Frequency of asthma exacerbations not increased with live attenuated versus inactivated flu vaccine in children aged 5 to 17 years with asthma
Biden Administration to Offer Second COVID-19 Boosters to Those 50+
While a second booster for older adults will be offered, federal health officials will not go so far as to recommend it
Risk for Blood Clots After COVID-19 Vaccination Explored
Two studies show increase in intracranial venous thrombosis, thrombocytopenia for those younger than 70 years and in CVST after ChAdOx1-S
Physician’s Briefing Weekly Coronavirus Roundup
Interim Estimate Suggests Flu Shot Not Effective in 2021-2022 Season
Vaccine effectiveness against medically attended outpatient acute respiratory infection associated with A(H3N2) was 16 percent